financetom
Business
financetom
/
Business
/
EV maker Lucid's quarterly deliveries rise but fall short of expectations
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EV maker Lucid's quarterly deliveries rise but fall short of expectations
Oct 6, 2025 1:41 PM

(Reuters) -Lucid reported a 46.6% jump in third-quarter deliveries on Monday, driven by a rush of demand for electric vehicles before lucrative tax credits expired last week, but it still missed Wall Street expectations.

The EV maker and its rivals are bracing for a sharp drop in sales in the last three months of the year without the $7,500 in credits. While some have cut prices and found mechanisms to extend the benefits of the credit, others have cut production plans in anticipation of a slump.

Lucid lowered its annual production forecast in August and now expects to make between 18,000 and 20,000 vehicles this year. Five analysts are expecting the company to produce about 17,800 vehicles on average, according to Visible Alpha.

The EV industry has already been grappling with high tariffs on imports of vehicles and auto parts into the U.S.

While Lucid makes its vehicles in the U.S., it imports some parts from abroad. Lucid vehicles did not qualify for the tax credits on cash purchases, but it used the credits to offer attractive leases.

Lucid handed over 4,078 vehicles in the quarter, compared with estimates of 4,286 deliveries seven analysts, on average, were expecting, according to Visible Alpha. This compares with 2,781 vehicles delivered a year ago.

EV giant Tesla posted record quarterly deliveries on Thursday, while Rivian also beat sales estimates as consumers rushed to buy EVs ahead of the incentive's September 30 deadline.

The company has put in place offers and discounts to boost the appeal of its luxury Air sedans to attract consumers who have pared back big-budget spending because of high interest rates.

The EV maker has been aggressively striking deals with North American companies to domestically source critical minerals used in manufacturing.

The company's fortunes rely heavily on the success of its newly launched Gravity SUV and the upcoming mid-size car, which targets a $50,000 price point, as the company looks to expand its consumer base.  

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Data Storage Signs Agreement to Sell Subsidiary; Shares Rise Premarket
Data Storage Signs Agreement to Sell Subsidiary; Shares Rise Premarket
Jul 16, 2025
05:18 AM EDT, 07/16/2025 (MT Newswires) -- Data Storage ( DTST ) said late Tuesday it struck a deal to sell its subsidiary, CloudFirst Technologies, to Performive. The sale is subject to shareholder approval at Data Storage's ( DTST ) annual meeting on Sept. 10. The move aims to enable Data Storage ( DTST ) to repurchase up to 85%...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Update: Market Chatter: Brighthouse Financial Could be Acquired by Aquarian in Weeks
Update: Market Chatter: Brighthouse Financial Could be Acquired by Aquarian in Weeks
Jul 16, 2025
05:19 AM EDT, 07/16/2025 (MT Newswires) -- (Updates with stock price movement in the last paragraph.) Brighthouse Financial ( BHF ) is in talks with Aquarian Holdings regarding an acquisition by the investment firm, The Wall Street Journal reported late Tuesday, citing sources. The buyout of the US insurer could be completed within weeks, people familiar with the matter told...
AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
AstraZeneca therapy for clearing protein deposits fails main goal in late-stage study
Jul 16, 2025
(Reuters) -AstraZeneca's ( AZN ) experimental therapy anselamimab did not meet the main goal of a late-stage study for the treatment of a rare condition that causes a buildup of protein deposits in the body, the drugmaker said on Wednesday, sending shares down 1.3%. The study was assessing a combination of how often patients with advanced, heart-related AL amyloidosis were...
Copyright 2023-2026 - www.financetom.com All Rights Reserved